Apoptosis, cancer and cancer therapy

R. J. Bold, P. M. Termuhlen, D. J. McConkey

Research output: Contribution to journalReview article

213 Citations (Scopus)

Abstract

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis. Apoptosis is essential in the homeostasis of normal tissues of the body, especially those of the gastrointestinal tract, immune system and skin. There is increasing evidence that the processes of neoplastic transformation, progression and metastasis involve alterations in the normal apoptotic pathways. Furthermore, the majority of chemotherapeutic agents as well as radiation utilize the apoptotic pathway to induce cancer cell death. Resistance to standard chemotherapies also seems to be determined by alterations in the apoptotic pathways of cancer cells. Therefore, understanding the signals of apoptosis and the mechanism of apoptosis may allow the development of better chemo- or radio-therapeutic regimens for the treatment of cancer. Finally, components of the apoptotic pathway may represent potential therapeutic targets using gene therapy techniques.

Original languageEnglish (US)
Pages (from-to)133-142
Number of pages10
JournalSurgical Oncology
Volume6
Issue number3
DOIs
StatePublished - Dec 1 1997

Fingerprint

Apoptosis
Neoplasms
Cell Death
Neoplastic Processes
Therapeutics
Radio
Genetic Therapy
Gastrointestinal Tract
Immune System
Homeostasis
Necrosis
Radiation
Neoplasm Metastasis
Drug Therapy
Skin

Keywords

  • Apoptosis
  • Chemotherapy
  • Metastasis
  • Radiotherapy
  • bcl-2

Cite this

Apoptosis, cancer and cancer therapy. / Bold, R. J.; Termuhlen, P. M.; McConkey, D. J.

In: Surgical Oncology, Vol. 6, No. 3, 01.12.1997, p. 133-142.

Research output: Contribution to journalReview article

Bold, R. J. ; Termuhlen, P. M. ; McConkey, D. J. / Apoptosis, cancer and cancer therapy. In: Surgical Oncology. 1997 ; Vol. 6, No. 3. pp. 133-142.
@article{8f6c8e379a134df49443155e1b538378,
title = "Apoptosis, cancer and cancer therapy",
abstract = "Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis. Apoptosis is essential in the homeostasis of normal tissues of the body, especially those of the gastrointestinal tract, immune system and skin. There is increasing evidence that the processes of neoplastic transformation, progression and metastasis involve alterations in the normal apoptotic pathways. Furthermore, the majority of chemotherapeutic agents as well as radiation utilize the apoptotic pathway to induce cancer cell death. Resistance to standard chemotherapies also seems to be determined by alterations in the apoptotic pathways of cancer cells. Therefore, understanding the signals of apoptosis and the mechanism of apoptosis may allow the development of better chemo- or radio-therapeutic regimens for the treatment of cancer. Finally, components of the apoptotic pathway may represent potential therapeutic targets using gene therapy techniques.",
keywords = "Apoptosis, Chemotherapy, Metastasis, Radiotherapy, bcl-2",
author = "Bold, {R. J.} and Termuhlen, {P. M.} and McConkey, {D. J.}",
year = "1997",
month = "12",
day = "1",
doi = "10.1016/S0960-7404(97)00015-7",
language = "English (US)",
volume = "6",
pages = "133--142",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Apoptosis, cancer and cancer therapy

AU - Bold, R. J.

AU - Termuhlen, P. M.

AU - McConkey, D. J.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis. Apoptosis is essential in the homeostasis of normal tissues of the body, especially those of the gastrointestinal tract, immune system and skin. There is increasing evidence that the processes of neoplastic transformation, progression and metastasis involve alterations in the normal apoptotic pathways. Furthermore, the majority of chemotherapeutic agents as well as radiation utilize the apoptotic pathway to induce cancer cell death. Resistance to standard chemotherapies also seems to be determined by alterations in the apoptotic pathways of cancer cells. Therefore, understanding the signals of apoptosis and the mechanism of apoptosis may allow the development of better chemo- or radio-therapeutic regimens for the treatment of cancer. Finally, components of the apoptotic pathway may represent potential therapeutic targets using gene therapy techniques.

AB - Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis. Apoptosis is essential in the homeostasis of normal tissues of the body, especially those of the gastrointestinal tract, immune system and skin. There is increasing evidence that the processes of neoplastic transformation, progression and metastasis involve alterations in the normal apoptotic pathways. Furthermore, the majority of chemotherapeutic agents as well as radiation utilize the apoptotic pathway to induce cancer cell death. Resistance to standard chemotherapies also seems to be determined by alterations in the apoptotic pathways of cancer cells. Therefore, understanding the signals of apoptosis and the mechanism of apoptosis may allow the development of better chemo- or radio-therapeutic regimens for the treatment of cancer. Finally, components of the apoptotic pathway may represent potential therapeutic targets using gene therapy techniques.

KW - Apoptosis

KW - Chemotherapy

KW - Metastasis

KW - Radiotherapy

KW - bcl-2

UR - http://www.scopus.com/inward/record.url?scp=0031424574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031424574&partnerID=8YFLogxK

U2 - 10.1016/S0960-7404(97)00015-7

DO - 10.1016/S0960-7404(97)00015-7

M3 - Review article

C2 - 9576629

AN - SCOPUS:0031424574

VL - 6

SP - 133

EP - 142

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 3

ER -